Literature DB >> 12728157

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.

D M Mannino1, A S Buist, T L Petty, P L Enright, S C Redd.   

Abstract

BACKGROUND: A study was undertaken to define the risk of death among a national cohort of US adults both with and without lung disease.
METHODS: Participants in the first National Health and Nutrition Examination Survey (NHANES I) followed for up to 22 years were studied. Subjects were classified using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria for chronic obstructive pulmonary disease (COPD) into the following mutually exclusive categories using the forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1)/FVC ratio, and the presence of respiratory symptoms: severe COPD, moderate COPD, mild COPD, respiratory symptoms only, restrictive lung disease, and no lung disease. Proportional hazard models were developed that controlled for age, race, sex, education, smoking status, pack years of smoking, years since quitting smoking, and body mass index.
RESULTS: A total of 1301 deaths occurred in the 5542 adults in the cohort. In the adjusted proportional hazards model the presence of severe or moderate COPD was associated with a higher risk of death (hazard ratios (HR) 2.7 and 1.6, 95% confidence intervals (CI) 2.1 to 3.5 and 1.4 to 2.0), as was restrictive lung disease (HR 1.7, 95% CI 1.4 to 2.0).
CONCLUSIONS: The presence of both obstructive and restrictive lung disease is a significant predictor of earlier death in long term follow up.

Entities:  

Mesh:

Year:  2003        PMID: 12728157      PMCID: PMC1746680          DOI: 10.1136/thorax.58.5.388

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  29 in total

Review 1.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

2.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Authors:  D M Mannino; R C Gagnon; T L Petty; E Lydick
Journal:  Arch Intern Med       Date:  2000-06-12

3.  How accurate is spirometry at predicting restrictive pulmonary impairment?

Authors:  S D Aaron; R E Dales; P Cardinal
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

4.  Pulmonary function levels as predictors of mortality in a national sample of US adults.

Authors:  L M Neas; J Schwartz
Journal:  Am J Epidemiol       Date:  1998-06-01       Impact factor: 4.897

5.  Plan and operation of the NHANES I Epidemiologic Followup Study, 1992.

Authors:  C S Cox; M E Mussolino; S T Rothwell; M A Lane; C D Golden; J H Madans; J J Feldman
Journal:  Vital Health Stat 1       Date:  1997-12

6.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

7.  Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Authors:  M Pelkonen; H Tukiainen; M Tervahauta; I L Notkola; S L Kivelä; Y Salorinne; A Nissinen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

8.  Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study.

Authors:  M W Knuiman; A L James; M L Divitini; G Ryan; H C Bartholomew; A W Musk
Journal:  Ann Epidemiol       Date:  1999-07       Impact factor: 3.797

9.  Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study.

Authors:  H J Schünemann; J Dorn; B J Grant; W Winkelstein; M Trevisan
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

10.  Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men.

Authors:  D S Sharp; K Masaki; C M Burchfiel; K Yano; I J Schatz
Journal:  Ann Epidemiol       Date:  1998-02       Impact factor: 3.797

View more
  192 in total

1.  Diffusing capacity predicts long-term survival after lung resection for cancer.

Authors:  Mark K Ferguson; James J Dignam; Juned Siddique; Wickii T Vigneswaran; Amy D Celauro
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-24       Impact factor: 4.191

2.  Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.

Authors:  D M Mannino
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

3.  Spirometric screening: Does it work?

Authors:  D M Mannino
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

4.  Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Authors:  Michael Spencer; Andrew H Briggs; Ronald F Grossman; Laureen Rance
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

Review 6.  Alcohol and airways function in health and disease.

Authors:  Joseph H Sisson
Journal:  Alcohol       Date:  2007-08-30       Impact factor: 2.405

7.  Predictors of cardiopulmonary hospitalization in chronic spinal cord injury.

Authors:  Anthony C Waddimba; Nitin B Jain; Kelly Stolzmann; David R Gagnon; James F Burgess; Lewis E Kazis; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

Review 8.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

9.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

10.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.